The Market Reports
Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com
Edaravone-Global Market Insights and Sales Trends 2025
Synopsis
The global Edaravone market size is expected to reach US$ 1346.7 million by 2029, growing at a CAGR of 4.6% from 2023 to 2029. The market is mainly driven by the significant applications of Edaravone in various end use industries. The expanding demands from the Hospital, Clinic and Others,, are propelling Edaravone market. Oral Edaravone, one of the segments analysed in this report, is projected to record % CAGR and reach US$ million by the end of the analysis period. Growth in the Injection Edaravone segment is estimated at % CAGR for the next seven-year period.
Asia Pacific shows high growth potential for Edaravone market, driven by demand from China, the second largest economy with some signs of stabilising, the Edaravone market in China is forecast to reach US$ million by 2029, trailing a CAGR of % over the 2023-2029 period, while the U.S. market will reach US$ million by 2029, exhibiting a CAGR of % during the same period.
Report Objectives
This report provides market insight on the different segments, by manufacturers, by Type, by Application. Market size and forecast (2018-2029) has been provided in the report. The primary objectives of this report are to provide 1) global market size and forecasts, growth rates, market dynamics, industry structure and developments, market situation, trends; 2) global market share and ranking by company; 3) comprehensive presentation of the global market for Edaravone, with both quantitative and qualitative analysis through detailed segmentation; 4) detailed value chain analysis and review of growth factors essential for the existing market players and new entrants; 5) emerging opportunities in the market and the future impact of major drivers and restraints of the market.
Key Features of The Study:
This report provides in-depth analysis of the global Edaravone market, and provides market size (US$ million) and CAGR for the forecast period (2023-2029), considering 2022 as the base year.
This report profiles key players in the global Edaravone market based on the following parameters - company details (found date, headquarters, manufacturing bases), products portfolio, Edaravone sales data, market share and ranking.
This report elucidates potential market opportunities across different segments and explains attractive investment proposition matrices for this market.
This report illustrates key insights about market drivers, restraints, opportunities, market trends, regional outlook.
Key companies of Edaravone covered in this report include Mitsubishi Tanabe Pharma, Simcere, Taj Pharmaceuticals Ltd., Sun Pharmaceutical Industries Ltd., Unichem Laboratories Ltd, UCB India Ltd and Piramal Healthcare, etc.
The global Edaravone market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts.
Market Segmentation
Company Profiles:
Mitsubishi Tanabe Pharma
Simcere
Taj Pharmaceuticals Ltd.
Sun Pharmaceutical Industries Ltd.
Unichem Laboratories Ltd
UCB India Ltd
Piramal Healthcare
Global Edaravone market, by region:
North America (U.S., Canada, Mexico)
Europe (Germany, France, UK, Italy, etc.)
Asia Pacific (China, Japan, South Korea, Southeast Asia, India, etc.)
South America (Brazil, etc.)
Middle East and Africa (Turkey, GCC Countries, Africa, etc.)
Global Edaravone market, Segment by Type:
Oral Edaravone
Injection Edaravone
Global Edaravone market, by Application
Hospital
Clinic
Others
Core Chapters
Chapter One: Introduces the study scope of this report, executive summary of market segments by Type, market size segments for North America, Europe, Asia Pacific, South America, Middle East & Africa.
Chapter Two: Detailed analysis of Edaravone manufacturers competitive landscape, price, sales, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.
Chapter Three: Sales, revenue of Edaravone in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the future development prospects, and market space in the world.
Chapter Four: Introduces market segments by Application, market size segment for North America, Europe, Asia Pacific, South America, Middle East & Africa.
Chapter Five, Six, Seven, Eight and Nine: North America, Europe, Asia Pacific, South America, Middle East & Africa, sales and revenue by country.
Chapter Ten: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter Eleven: Analysis of industrial chain, key raw materials, manufacturing cost, and market dynamics. Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter Twelve: Analysis of sales channel, distributors and customers.
Chapter Thirteen: Research Findings and Conclusion.
The global Edaravone market size is expected to reach US$ 1346.7 million by 2029, growing at a CAGR of 4.6% from 2023 to 2029. The market is mainly driven by the significant applications of Edaravone in various end use industries. The expanding demands from the Hospital, Clinic and Others,, are propelling Edaravone market. Oral Edaravone, one of the segments analysed in this report, is projected to record % CAGR and reach US$ million by the end of the analysis period. Growth in the Injection Edaravone segment is estimated at % CAGR for the next seven-year period.
Asia Pacific shows high growth potential for Edaravone market, driven by demand from China, the second largest economy with some signs of stabilising, the Edaravone market in China is forecast to reach US$ million by 2029, trailing a CAGR of % over the 2023-2029 period, while the U.S. market will reach US$ million by 2029, exhibiting a CAGR of % during the same period.
Report Objectives
This report provides market insight on the different segments, by manufacturers, by Type, by Application. Market size and forecast (2018-2029) has been provided in the report. The primary objectives of this report are to provide 1) global market size and forecasts, growth rates, market dynamics, industry structure and developments, market situation, trends; 2) global market share and ranking by company; 3) comprehensive presentation of the global market for Edaravone, with both quantitative and qualitative analysis through detailed segmentation; 4) detailed value chain analysis and review of growth factors essential for the existing market players and new entrants; 5) emerging opportunities in the market and the future impact of major drivers and restraints of the market.
Key Features of The Study:
This report provides in-depth analysis of the global Edaravone market, and provides market size (US$ million) and CAGR for the forecast period (2023-2029), considering 2022 as the base year.
This report profiles key players in the global Edaravone market based on the following parameters - company details (found date, headquarters, manufacturing bases), products portfolio, Edaravone sales data, market share and ranking.
This report elucidates potential market opportunities across different segments and explains attractive investment proposition matrices for this market.
This report illustrates key insights about market drivers, restraints, opportunities, market trends, regional outlook.
Key companies of Edaravone covered in this report include Mitsubishi Tanabe Pharma, Simcere, Taj Pharmaceuticals Ltd., Sun Pharmaceutical Industries Ltd., Unichem Laboratories Ltd, UCB India Ltd and Piramal Healthcare, etc.
The global Edaravone market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts.
Market Segmentation
Company Profiles:
Mitsubishi Tanabe Pharma
Simcere
Taj Pharmaceuticals Ltd.
Sun Pharmaceutical Industries Ltd.
Unichem Laboratories Ltd
UCB India Ltd
Piramal Healthcare
Global Edaravone market, by region:
North America (U.S., Canada, Mexico)
Europe (Germany, France, UK, Italy, etc.)
Asia Pacific (China, Japan, South Korea, Southeast Asia, India, etc.)
South America (Brazil, etc.)
Middle East and Africa (Turkey, GCC Countries, Africa, etc.)
Global Edaravone market, Segment by Type:
Oral Edaravone
Injection Edaravone
Global Edaravone market, by Application
Hospital
Clinic
Others
Core Chapters
Chapter One: Introduces the study scope of this report, executive summary of market segments by Type, market size segments for North America, Europe, Asia Pacific, South America, Middle East & Africa.
Chapter Two: Detailed analysis of Edaravone manufacturers competitive landscape, price, sales, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.
Chapter Three: Sales, revenue of Edaravone in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the future development prospects, and market space in the world.
Chapter Four: Introduces market segments by Application, market size segment for North America, Europe, Asia Pacific, South America, Middle East & Africa.
Chapter Five, Six, Seven, Eight and Nine: North America, Europe, Asia Pacific, South America, Middle East & Africa, sales and revenue by country.
Chapter Ten: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter Eleven: Analysis of industrial chain, key raw materials, manufacturing cost, and market dynamics. Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter Twelve: Analysis of sales channel, distributors and customers.
Chapter Thirteen: Research Findings and Conclusion.
Index1 Edaravone Market Overview
1.1 Edaravone Product Overview
1.2 Edaravone Market Segment by Type
1.2.1 Oral Edaravone
1.2.2 Injection Edaravone
1.3 Global Edaravone Market Size by Type
1.3.1 Global Edaravone Market Size Overview by Type (2018-2029)
1.3.2 Global Edaravone Historic Market Size Review by Type (2018-2023)
1.3.3 Global Edaravone Forecasted Market Size by Type (2024-2029)
1.4 Key Regions Market Size Segment by Type
1.4.1 North America Edaravone Sales Breakdown by Type (2018-2023)
1.4.2 Europe Edaravone Sales Breakdown by Type (2018-2023)
1.4.3 Asia-Pacific Edaravone Sales Breakdown by Type (2018-2023)
1.4.4 Latin America Edaravone Sales Breakdown by Type (2018-2023)
1.4.5 Middle East and Africa Edaravone Sales Breakdown by Type (2018-2023)
2 Global Edaravone Market Competition by Company
2.1 Global Top Players by Edaravone Sales (2018-2023)
2.2 Global Top Players by Edaravone Revenue (2018-2023)
2.3 Global Top Players by Edaravone Price (2018-2023)
2.4 Global Top Manufacturers Edaravone Manufacturing Base Distribution, Sales Area, Product Type
2.5 Edaravone Market Competitive Situation and Trends
2.5.1 Edaravone Market Concentration Rate (2018-2023)
2.5.2 Global 5 and 10 Largest Manufacturers by Edaravone Sales and Revenue in 2022
2.6 Global Top Manufacturers by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Edaravone as of 2022)
2.7 Date of Key Manufacturers Enter into Edaravone Market
2.8 Key Manufacturers Edaravone Product Offered
2.9 Mergers & Acquisitions, Expansion
3 Edaravone Status and Outlook by Region
3.1 Global Edaravone Market Size and CAGR by Region: 2018 VS 2022 VS 2029
3.2 Global Edaravone Historic Market Size by Region
3.2.1 Global Edaravone Sales in Volume by Region (2018-2023)
3.2.2 Global Edaravone Sales in Value by Region (2018-2023)
3.2.3 Global Edaravone Sales (Volume & Value) Price and Gross Margin (2018-2023)
3.3 Global Edaravone Forecasted Market Size by Region
3.3.1 Global Edaravone Sales in Volume by Region (2024-2029)
3.3.2 Global Edaravone Sales in Value by Region (2024-2029)
3.3.3 Global Edaravone Sales (Volume & Value), Price and Gross Margin (2024-2029)
4 Global Edaravone by Application
4.1 Edaravone Market Segment by Application
4.1.1 Hospital
4.1.2 Clinic
4.1.3 Others
4.2 Global Edaravone Market Size by Application
4.2.1 Global Edaravone Market Size Overview by Application (2018-2029)
4.2.2 Global Edaravone Historic Market Size Review by Application (2018-2023)
4.2.3 Global Edaravone Forecasted Market Size by Application (2024-2029)
4.3 Key Regions Market Size Segment by Application
4.3.1 North America Edaravone Sales Breakdown by Application (2018-2023)
4.3.2 Europe Edaravone Sales Breakdown by Application (2018-2023)
4.3.3 Asia-Pacific Edaravone Sales Breakdown by Application (2018-2023)
4.3.4 Latin America Edaravone Sales Breakdown by Application (2018-2023)
4.3.5 Middle East and Africa Edaravone Sales Breakdown by Application (2018-2023)
5 North America Edaravone by Country
5.1 North America Edaravone Historic Market Size by Country
5.1.1 North America Edaravone Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2029
5.1.2 North America Edaravone Sales in Volume by Country (2018-2023)
5.1.3 North America Edaravone Sales in Value by Country (2018-2023)
5.2 North America Edaravone Forecasted Market Size by Country
5.2.1 North America Edaravone Sales in Volume by Country (2024-2029)
5.2.2 North America Edaravone Sales in Value by Country (2024-2029)
6 Europe Edaravone by Country
6.1 Europe Edaravone Historic Market Size by Country
6.1.1 Europe Edaravone Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2029
6.1.2 Europe Edaravone Sales in Volume by Country (2018-2023)
6.1.3 Europe Edaravone Sales in Value by Country (2018-2023)
6.2 Europe Edaravone Forecasted Market Size by Country
6.2.1 Europe Edaravone Sales in Volume by Country (2024-2029)
6.2.2 Europe Edaravone Sales in Value by Country (2024-2029)
7 Asia-Pacific Edaravone by Region
7.1 Asia-Pacific Edaravone Historic Market Size by Region
7.1.1 Asia-Pacific Edaravone Market Size Growth Rate (CAGR) by Region: 2018 VS 2022 VS 2029
7.1.2 Asia-Pacific Edaravone Sales in Volume by Region (2018-2023)
7.1.3 Asia-Pacific Edaravone Sales in Value by Region (2018-2023)
7.2 Asia-Pacific Edaravone Forecasted Market Size by Region
7.2.1 Asia-Pacific Edaravone Sales in Volume by Region (2024-2029)
7.2.2 Asia-Pacific Edaravone Sales in Value by Region (2024-2029)
8 Latin America Edaravone by Country
8.1 Latin America Edaravone Historic Market Size by Country
8.1.1 Latin America Edaravone Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2029
8.1.2 Latin America Edaravone Sales in Volume by Country (2018-2023)
8.1.3 Latin America Edaravone Sales in Value by Country (2018-2023)
8.2 Latin America Edaravone Forecasted Market Size by Country
8.2.1 Latin America Edaravone Sales in Volume by Country (2024-2029)
8.2.2 Latin America Edaravone Sales in Value by Country (2024-2029)
9 Middle East and Africa Edaravone by Country
9.1 Middle East and Africa Edaravone Historic Market Size by Country
9.1.1 Middle East and Africa Edaravone Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2029
9.1.2 Middle East and Africa Edaravone Sales in Volume by Country (2018-2023)
9.1.3 Middle East and Africa Edaravone Sales in Value by Country (2018-2023)
9.2 Middle East and Africa Edaravone Forecasted Market Size by Country
9.2.1 Middle East and Africa Edaravone Sales in Volume by Country (2024-2029)
9.2.2 Middle East and Africa Edaravone Sales in Value by Country (2024-2029)
10 Company Profiles
10.1 Mitsubishi Tanabe Pharma
10.1.1 Mitsubishi Tanabe Pharma Company Information
10.1.2 Mitsubishi Tanabe Pharma Introduction and Business Overview
10.1.3 Mitsubishi Tanabe Pharma Edaravone Sales, Revenue and Gross Margin (2018-2023)
10.1.4 Mitsubishi Tanabe Pharma Edaravone Products Offered
10.1.5 Mitsubishi Tanabe Pharma Recent Development
10.2 Simcere
10.2.1 Simcere Company Information
10.2.2 Simcere Introduction and Business Overview
10.2.3 Simcere Edaravone Sales, Revenue and Gross Margin (2018-2023)
10.2.4 Simcere Edaravone Products Offered
10.2.5 Simcere Recent Development
10.3 Taj Pharmaceuticals Ltd.
10.3.1 Taj Pharmaceuticals Ltd. Company Information
10.3.2 Taj Pharmaceuticals Ltd. Introduction and Business Overview
10.3.3 Taj Pharmaceuticals Ltd. Edaravone Sales, Revenue and Gross Margin (2018-2023)
10.3.4 Taj Pharmaceuticals Ltd. Edaravone Products Offered
10.3.5 Taj Pharmaceuticals Ltd. Recent Development
10.4 Sun Pharmaceutical Industries Ltd.
10.4.1 Sun Pharmaceutical Industries Ltd. Company Information
10.4.2 Sun Pharmaceutical Industries Ltd. Introduction and Business Overview
10.4.3 Sun Pharmaceutical Industries Ltd. Edaravone Sales, Revenue and Gross Margin (2018-2023)
10.4.4 Sun Pharmaceutical Industries Ltd. Edaravone Products Offered
10.4.5 Sun Pharmaceutical Industries Ltd. Recent Development
10.5 Unichem Laboratories Ltd
10.5.1 Unichem Laboratories Ltd Company Information
10.5.2 Unichem Laboratories Ltd Introduction and Business Overview
10.5.3 Unichem Laboratories Ltd Edaravone Sales, Revenue and Gross Margin (2018-2023)
10.5.4 Unichem Laboratories Ltd Edaravone Products Offered
10.5.5 Unichem Laboratories Ltd Recent Development
10.6 UCB India Ltd
10.6.1 UCB India Ltd Company Information
10.6.2 UCB India Ltd Introduction and Business Overview
10.6.3 UCB India Ltd Edaravone Sales, Revenue and Gross Margin (2018-2023)
10.6.4 UCB India Ltd Edaravone Products Offered
10.6.5 UCB India Ltd Recent Development
10.7 Piramal Healthcare
10.7.1 Piramal Healthcare Company Information
10.7.2 Piramal Healthcare Introduction and Business Overview
10.7.3 Piramal Healthcare Edaravone Sales, Revenue and Gross Margin (2018-2023)
10.7.4 Piramal Healthcare Edaravone Products Offered
10.7.5 Piramal Healthcare Recent Development
11 Upstream, Opportunities, Challenges, Risks and Influences Factors Analysis
11.1 Edaravone Key Raw Materials
11.1.1 Key Raw Materials
11.1.2 Key Raw Materials Price
11.1.3 Raw Materials Key Suppliers
11.2 Manufacturing Cost Structure
11.2.1 Raw Materials
11.2.2 Labor Cost
11.2.3 Manufacturing Expenses
11.3 Edaravone Industrial Chain Analysis
11.4 Edaravone Market Dynamics
11.4.1 Edaravone Industry Trends
11.4.2 Edaravone Market Drivers
11.4.3 Edaravone Market Challenges
11.4.4 Edaravone Market Restraints
12 Market Strategy Analysis, Distributors
12.1 Sales Channel
12.2 Edaravone Distributors
12.3 Edaravone Downstream Customers
13 Research Findings and Conclusion
14 Appendix
14.1 Research Methodology
14.1.1 Methodology/Research Approach
14.1.2 Data Source
14.2 Author Details
14.3 Disclaimer
Published By : QY Research
Why ‘The Market Reports’
In Business:
Pre Sales Support:
Post Sales Support:
Turn Around Time:
Clients Served:
Clients Assisted:
Client Types:
Payment:
- Accept global payments [Credit Card / PayPal / Wire Transfer]
- Accept local payments in South Korea, Germany, China and India [Can pay in local currency]
Latest Life Science Market Reports
Payments Accepted From
Connect with us at
Complete Secure Website
